Benztropine Mesylate
Product Images NDC 10858-011

2 FDA label images from Wintac Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 10858-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wintac Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (67ef7746 45bc 466b A7b7 353c8b8702c1 01)

Vial (67ef7746 45bc 466b A7b7 353c8b8702c1 01)
Label for benztropine mesylate injection USP 2 mg/2 mL (1 mg/mL) presented as a 2 mL single-dose vial. Intended for intravenous or intramuscular use. Label includes storage instructions and manufacturer details: Navinta LLC, Ewing, NJ, with Wintac Limited as the labeler. NDC 10858-011-01 shown.*
FDA Label Image

Carton (67ef7746 45bc 466b A7b7 353c8b8702c1 02)

Carton (67ef7746 45bc 466b A7b7 353c8b8702c1 02)
Packaging label for Benztropine Mesylate Injection, USP 2 mg/2 mL (1 mg/mL) by Wintac Limited. The label indicates use for intravenous or intramuscular injection and contains 5 single-dose vials of 2 mL each. The label includes ingredient information and usage instructions, along with barcodes and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.